drugset / Trial / NCT00963040
Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this prospective, randomized, double-blind, parallel-group, placebo-controlled study is to determine the effectiveness of intranasal oxytocin in subjects suffering from chronic daily headache.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | 32 iu | Intranasal |
| Subject | Oxytocin | Peptide | 64 iu | Intranasal |